ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Mississippi » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in Mississippi

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOHN PRATHER M.D.

Cardiovascular Disease

17,624

$750K

1028
849 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 26%

$43
Average prescription price

Avg: $49

DHARMESH PATEL MD

Cardiovascular Disease

15,197

$900K

1079
845 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 26%

$59
Average prescription price

Avg: $49

MAHMOUD ZAYED MD

Cardiovascular Disease

12,853

$858K

900
752 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 26%

$67
Average prescription price

Avg: $49

WASSIM MOUANNES MD

Cardiovascular Disease

11,406

$504K

757
530 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $49

NANNI PIDIKITI M.D.

Cardiovascular Disease

11,009

$431K

554
383 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 26%

$39
Average prescription price

Avg: $49

ERIC ENGER MD

Cardiovascular Disease

10,600

$545K

829
670 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

1%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $49

DALE TOUCHSTONE M.D.

Cardiovascular Disease

10,514

$287K

613
509 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 26%

$27
Average prescription price

Avg: $49

MANOJ SHAH MD

Cardiovascular Disease

10,419

$492K

601
433 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 26%

$47
Average prescription price

Avg: $49

HUGO QUINTANA MD

Cardiovascular Disease

10,291

$609K

758
604 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 26%

$59
Average prescription price

Avg: $49

JEFFREY MORRIS MD

Cardiovascular Disease

9,991

$815K

322
233 are 65+

12%
patients receiving schedule two controlled substances

Avg: 1%

23%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 26%

$82
Average prescription price

Avg: $49

DAVID YOUNG MD

Cardiovascular Disease

9,940

$508K

682
555 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $49

BARRY BERTOLET MD

Cardiovascular Disease

9,323

$489K

953
748 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $49

CHARLES MOORE MD

Cardiovascular Disease

9,215

$531K

391
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 26%

$58
Average prescription price

Avg: $49

FISHER COVIN M.D.

Cardiovascular Disease

9,177

$427K

1001
754 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 26%

$47
Average prescription price

Avg: $49

JAMES WILLIAMS MD

Cardiovascular Disease

9,140

$417K

686
509 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $49

EMAD MOHAMED M.D.

Cardiovascular Disease

9,099

$457K

607
389 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $49

ALI HOMAYUNI MD

Cardiovascular Disease

9,087

$391K

680
492 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 26%

$43
Average prescription price

Avg: $49

WILLIAM PASSARELLI MD

Cardiovascular Disease

8,951

$673K

620
478 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 26%

$75
Average prescription price

Avg: $49

JOSEPH PROLI MD

Cardiovascular Disease

8,751

$360K

529
420 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 26%

$41
Average prescription price

Avg: $49

GEORGE REYNOLDS M.D.

Cardiovascular Disease

8,362

$339K

551
439 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 26%

$41
Average prescription price

Avg: $49

JAMES WARNOCK M.D.

Cardiovascular Disease

8,359

$519K

595
490 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 26%

$62
Average prescription price

Avg: $49

KERRY MORGAN M.D.

Cardiovascular Disease

8,141

$387K

551
397 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $49

WILLIAM SULLIVAN M.D.

Cardiovascular Disease

8,109

$247K

639
511 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 26%

$30
Average prescription price

Avg: $49

EDWARD EVANS MD

Cardiovascular Disease

8,038

$437K

568
410 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $49

MARK STRONG MD

Cardiovascular Disease

7,853

$287K

676
512 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 26%

$37
Average prescription price

Avg: $49

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank